Finals part II Flashcards

(40 cards)

1
Q

TDP-43 mutation

A

-accumulation in cell body of neuron(95%)

normally in nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SOD1 mutation

A
  • Superoxide normally converted to water

- with mutation SOD1 cannot breakdown superoxide radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment for ALS

A

RILUZOLE; increases uptake or clearance of glutamate from the synapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two characteristics of stem cells

A

1) unspecialized, indefinite self-renewal

2) can be induced to differentiate into specialized cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 types of stem cells

A

1) adult stem cells
2) embryonic stem cells(ES)
3) induced pluripotent stem cells(iPS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adult stem cells(somatic stem cells)

A
  • give rise to limited number of specialized cells

- normally kept in Go phase of cell cycle until activated by environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Embryonic stem cells(ES)

A
  • pluripotent, taken from inner cell mass of blastocyst

- however there are issues with ES therapeutics due to immune rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Induced Pluripotent Stem cells(iPS)

A
  • Pluripotent and easy to obtain
  • use 4 transcription factors; oct 4, SOX2, Klf4, and c-Myc
  • issue with c-Myc because it is oncogenic; caused 20% of mice to develop cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Percentage of cancer caused by somatic mutations?

A

90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

percentage of cancer caused by germline mutation(inherited)

A

5-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ocogenes

A
  • oncogenes result from gain of function mutation of proto-oncogenes
  • they are always on
  • receptor tyrosine kinases(RTKs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Receptor Tyrosin Kinases(RTKs)

A

-misregulation could lead to cancerous growth
two examples
-dimerization of receptors causes it to be active without a binding ligand
-gene for RTK ligand always activated, independent of cell signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Breast Cancer

A
  • Human EGF Receptor-2(HER2) is a type of RTK

- 30% have amplified HER2 activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of Breast Cancer

A
  • HERCEPTIN; it’s a monoclonal antibody that attaches to HER2
  • it tells body to target cancer cell
  • it inhibits HER2 signaling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clonal Evolution

A

-tumor develops through repeated round of mutation and proliferation giving rise to clone of fully malignant caner cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Colorectal Caner

A
  • by age 70, 50% of US adults have benign polyps; approx 10% of these develop cancer
  • activation of Ras-Raf-Mek-Mrk-MAP Kinase Cascade is cause of 20% of reported colon cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ALS genetic factors

A
  • SOD1(Cu/Zn SuperOxidase Dismutase)

- Defects in Chr 21; FUS/TDS, TDP-43

18
Q

What kind of mutation in Tumor suppressors causes cancer?

A

Loss of function

19
Q

what is the normal role of tumor suppressors ?

A
  • Protect cells from becoming cancerous

- tell cell when to die

20
Q

Two types of tumor suppressors

21
Q

What causes Leukemia?

A
  • The Philadelphia chromosome which is a result of acrocentric translocation between chromosome 9 and 22
  • this causes the fusion of Bcr and Abl genes
22
Q

Fusion of Bcr and Abl genes..

A
  • causes Bcr-Abl fusion protein

- Abl is normally a kinase, fusion causes it to be a super active kinase

23
Q

Treatment for Leukemia

A

Gleevec; targets the Bcr-Abl fusion protein, blocking the ATP binding site. Lack of ATP blocks cell proliferation signaling

24
Q

TDP-43 mutation

A

-accumulation in cell body of neuron(95%)

normally in nucleus

25
SOD1 mutation
- Superoxide normally converted to water | - with mutation SOD1 cannot breakdown superoxide radicals
26
Treatment for ALS
RILUZOLE; increases uptake or clearance of glutamate from the synapse
27
Two characteristics of stem cells
1) unspecialized, indefinite self-renewal | 2) can be induced to differentiate into specialized cells
28
3 types of stem cells
1) adult stem cells 2) embryonic stem cells(ES) 3) induced pluripotent stem cells(iPS)
29
Adult stem cells(somatic stem cells)
- give rise to limited number of specialized cells | - normally kept in Go phase of cell cycle until activated by environment
30
Embryonic stem cells(ES)
- pluripotent, taken from inner cell mass of blastocyst | - however there are issues with ES therapeutics due to immune rejection
31
Induced Pluripotent Stem cells(iPS)
- Pluripotent and easy to obtain - use 4 transcription factors; oct 4, SOX2, Klf4, and c-Myc - issue with c-Myc because it is oncogenic; caused 20% of mice to develop cancer
32
Percentage of cancer caused by somatic mutations?
90%
33
percentage of cancer caused by germline mutation(inherited)
5-10%
34
Ocogenes
- oncogenes result from gain of function mutation of proto-oncogenes - they are always on - receptor tyrosine kinases(RTKs)
35
Receptor Tyrosin Kinases(RTKs)
-misregulation could lead to cancerous growth two examples -dimerization of receptors causes it to be active without a binding ligand -gene for RTK ligand always activated, independent of cell signal
36
Breast Cancer
- Human EGF Receptor-2(HER2) is a type of RTK | - 30% have amplified HER2 activity
37
Treatment of Breast Cancer
- HERCEPTIN; it's a monoclonal antibody that attaches to HER2 - it tells body to target cancer cell - it inhibits HER2 signaling
38
Clonal Evolution
-tumor develops through repeated round of mutation and proliferation giving rise to clone of fully malignant caner cell
39
Colorectal Caner
- by age 70, 50% of US adults have benign polyps; approx 10% of these develop cancer - activation of Ras-Raf-Mek-Mrk-MAP Kinase Cascade is cause of 20% of reported colon cancer
40
ALS genetic factors
- SOD1(Cu/Zn SuperOxidase Dismutase) | - Defects in Chr 21; FUS/TDS, TDP-43